Purchase pharmaceutical company of "female Viagra" for $ 1 bi

A few days after having announced it would manufacture the "viagra" feminine, the Sprout Pharmaceuticals, Inc was acquired by Valeant Pharmaceuticals International, Inc. by 1 billion dollars.
Valeant announced the operation today, 20, two days after the Sprout had received authorization from the regulatory agency to manufacture the drug flibanserin, with trade name Addyi.
The drug has been approved to treat a condition known as "widespread hypoactive sexual desire disorder (HSDD)", which means the loss of libido.
ADVERTISEMENT
According to Hsbc, "Addyi come demonstrating improvements in sexual desire, reducing the stress caused by the loss of libido.
Sales of the medicine should start from the last quarter of 2015 in pharmacies and specialized clinics. The company will offer courses of diagnosis and prescription of Addyi in the United States.